Reliance Global Group (EZRA) Q3 2024 earnings summary

Executive summary

• Achieved 5% year-over-year revenue growth to $3.44 million for Q3 2024, driven by organic growth and effective cost management, resulting in improved net financial results and positive Adjusted EBITDA for the first time.

• Net loss for Q3 2024 was $837,314, a 54% improvement over the prior year’s comparable quarter when adjusted for non-recurring items, though the reported net loss widened due to non-cash asset impairments and lower warrant-related gains.

• The OneFirm strategy, unifying insurance agencies, drove efficiency, cross-selling, and cost reductions.

• The company is pursuing an aggressive acquisition strategy, including the pending acquisition of Spetner Associates for $13.7 million in cash, stock, and notes.

• A 1-for-17 reverse stock split was completed in July 2024 to support capital structure and compliance.

Financial highlights

• Q3 2024 revenue increased by 5% year-over-year to $3.44 million, with commission income rising and operating expenses declining 16% to $3.95 million.

• Adjusted EBITDA was a positive $42,508, a 121% improvement from the prior year.

• Net loss improved by $1 million (54%) compared to the same quarter last year, excluding a prior year warrant liability gain.

• Year-to-date revenues up 3% ($350,000); year-to-date EBITDA improved by 55%.

• Cash and restricted cash at quarter-end totaled $2.35 million, with working capital of $431,000.

Outlook and guidance

• Anticipates closing the acquisition of Spetner Associates, expected to nearly double consolidated revenues and accelerate growth.

• Integration of Spetner’s voluntary benefits segment, which has doubled its covered employees to 85,000, is expected to create substantial synergies.

• Focus remains on building a multi-billion dollar, highly profitable enterprise through expansion, innovation, and disciplined fiscal management.

• Management expects continued growth through acquisitions and organic expansion, focusing on insurance markets and InsurTech platforms.

• No substantial doubt about the company's ability to continue as a going concern for the next year.